Uro Medical

We are proud to announce Center for Medicare and Medicaid Services (CMS) coverage for participants in the GUARDIAN™ clinical trial, a multi-center randomized controlled clinical study evaluating the safety and efficacy of the Protect PNS neurostimulator medical device, as compared to traditional pharmaceutical medical management for the treatment for overactive bladder (OAB)

https://www.prnewswire.com/news-releases/uro-medical-wireless-microstimulator-secures-cms-coverage-of-2nd-clinical-trial-for-treatment-of-overactive-bladder-301578350.html

Uro Medical Wireless MicroStimulator Secures CMS Coverage of 2nd Clinical Trial for Treatment of Overactive Bladder /PRNewswire/ -- Uro Medical Corporation, a privately-held urology-focused medical device company engaged in the development, manufacture, and commercialization...

To our men and women in uniform, past, present, and future, thank you for your selfless service! Thank you for bravely doing what you’re called to do, so we can ALL safely do what we’re free to do.

https://www.globenewswire.com/news-release/2021/07/06/2258191/0/en/Uro-Medical-Corporation-Acquires-Micron-Medical-and-Initiates-the-FDA-IDE-Approved-Guardian-RCT-of-the-Protect-PNS-Injectable-Tibial-Stimulator-for-Treatment-of-Overactive-Bladder.html

Uro Medical Corporation Acquires Micron Medical and Initiates the FDA IDE Approved “Guardian” RCT of the Protect PNS Injectable Tibial Stimulator for Treatment of Overactive Bladder Uro Medical’s breakthrough injectable neuromodulation product, Protect PNS, is currently under regulatory review by the FDA for market approval...

The world's smallest Micro-Sized Impulse Generator! Check out our Live Cadaver Lab!

Knee Pain Slowing Your Patients Down? Join our Webinar! Knee Pain Slowing Your Patients Down? Learn more about Moventis PNS and how you and your patients can participate in a pioneering clinical trial (the FLEX study) to alleviate knee pa

The FDA’s 510(k) clearance of Moventis PNS, along with the PROTECT PNS De Novo submission application, provides the potential for Micron to offer an unmatched neuromodulation product offering to the urology community in 2021.

Read more about our latest announcements!

Micron Medical Receives FDA 510(k) Clearance for MOVENTIS PNS, a Drug-Free Wireless Peripheral Nerve Stimulator System for Common Urological Conditions; Commercial Launch Underway Submits De Novo 510(k) for Protect PNS for Treatment of OAB Symptoms

Micron Medical telemedicine PROTECT Study keeps you safe and potentially dry. Visit our website for more information: www.micronmed.com/eligibility

Incontinence Ruining your Quality of Life? Learn more about the PROTECT Study, a wireless no cost option! https://www.micronmed.com/eligibility

Micron Medical has implemented several new measures to help healthcare providers support their PROTECT Study OAB candidates remotely during the COVID-19 crisis.